What the hell is the SLA Board on about? - "waiting for increased production facility (for Ropren) before going into sales / pricing"
About October, 2005, SLA announced that it was well advanced in perfecting an improved delivery method for Ropren - IV, rather than oral, & this would reduce the required dose some 100-fold.
Thus, no new, expensive production facilities would be required as these minute dosages require only a small production facility; & of course a lot fewer tree branches to be harvested / carted / shredded / extracted.
The Board announced that "this improved delivery system for Ropren is expected to be completed by end 1st quarter, 2006".
All I've heard since is of bigger, expensive, new facilities to increase Ropren production to meet some belief of demand.
Where is the improved method for delivery of Ropren so that new production/extraction facilities are not needed?
SLA Price at posting:
31.3¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)